Best Practices for Youth: Transition to Care, Cultural Competence & Communication
Successful transition from pediatric to adult care for youth living with HIV is complex due to the coordinated medical and behavioral management required to reduce transmission risk. Adept navigation of co-occurring challenges, such as substance use, mental health conditions, and associated stigma and discrimination, is also essential. This webinar will explore strategies for successfully transitioning youth living with HIV to adult care, highlighting the importance of cultural competency and effective communication to this process.
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Learning Objectives
After completing this activity, the participant should be better able to:
- Recognize the trends of HIV and STIs among youth in DC.
- Describe the HPTS Transition Program Protocol
- Identify the challenges/barriers to successfully transition to Adult HIV care
- Discuss case studies on young adult patients who transition to adult HIV care
- Identify at least one unconscious judgment about youth and sex or sexuality
- Identify at least two problematic words/phrases related to HIV and appropriate substitutions
Other Related Trainings
Synergy in Care: Embracing and Empowering Community Healthcare Workers
This webinar explores the role of community health workers (CHWs) in improving health outcomes. The faculty will review strategies for integrating CHWs into clinical teams, effective communication and collaboration with CHWs, and best practices for supervision and training. Participants will also learn about the potential benefits and challenges of integrating CHWs into the clinical workforce.
The Heart of the Matter: Cardiovascular Health in People Living with HIV
This webinar will provide a comprehensive overview of cardiovascular disease (CVD) risk among people living with HIV and the underlying factors contributing to this risk. Participants will learn about current risk prediction tools available for assessing CVD risk in people living with HIV, as well as the findings and implications of the REPRIEVE trial.
